Clinical trial
Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors
NCT00070473 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00070473 |
|---|---|
| Title | Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors |
| Official title | A Phase I Study of Pemetrexed (LY231514, Alimta) in Children and Adolescents With Recurrent Solid Tumors |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | pemetrexed disodium |
| Enrollment | 33 |
| Start date | Oct 1, 2003 |
| Primary completion | Mar 1, 2006 |
| Completion | Jun 1, 2008 |
| First posted | Oct 7, 2003 |
| Last update posted | Feb 20, 2014 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: